Global Access Licensing

UAEM's response to call for comments on USPTO's proposed pilot program to grant priority review vouchers for technologies and licensing that benefits humanitarian needs and attached background documents.  

UAEM's recommendations for the strategies university technology transfer offices should adopt to promote global access to their technologies.

This is no longer the newest version.

An early precursor to the Philadelphia Consensus Statement, making recommendations for universities on making their health-related technologies available globally.

A 2006 paper published in PLoS Medicine's Student Forum by Dave Chokshi on the role of universities in promoting global access to medicines.

This article centers around a proposal outlining how research universities could leverage their intellectual property to help close the access gap for health innovations in poor countries. A recent deal between Emory University, Gilead Sciences, and Royalty Pharma is used as an example to illustrate how 'equitable access licensing' could be put into practice.

Published in Globalization & Health on February 1, 2007. Original version available from http://www.globalizationandhealth.com/content/3/1/1.

UAEM's reply (March 4, 2009) to University of California President Mark Yudof's letter (March 2, 2009).

Presentation introducing UAEM. Discusses the role of universities in reducing the research gap. Addresses patenting and licensing and the Philadelphia Consensus Statement.